Duncan Kennedy
Plus aucun poste en cours
Fortune : 16 485 $ au 31/03/2024
Historique de carrière de Duncan Kennedy
Anciens postes connus de Duncan Kennedy
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| JAMES FISHER AND SONS PLC | Director/Board Member | 04/05/2021 | 01/12/2023 |
| Director of Finance/CFO | 04/05/2021 | 01/12/2023 | |
| BTG | Director/Board Member | 01/01/2018 | 31/12/2019 |
| Director of Finance/CFO | 01/01/2018 | 31/12/2019 | |
| Corporate Officer/Principal | 14/03/2014 | 01/01/2018 |
Formation de Duncan Kennedy
| University of Durham | Undergraduate Degree |
Statistiques
Internationale
| Royaume-Uni | 4 |
Opérationnelle
| Director/Board Member | 2 |
| Director of Finance/CFO | 2 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 2 |
| Transportation | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| JAMES FISHER AND SONS PLC | Transportation |
| Entreprise privées | 1 |
|---|---|
BTG Ltd.
 BTG Ltd. Pharmaceuticals: MajorHealth Technology BTG Ltd. is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following segments: Product, Licensing, and Other. The firm's products include CroFab, DigiFab, Voraxage. The company was founded on December 12, 1991 and is headquartered in Farnham, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Duncan Kennedy
- Expérience
